CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation

Yara Banz(Beth Israel Deaconess Medical Center), Simon C. Robson(Beth Israel Deaconess Medical Center), Anny Usheva(Beth Israel Deaconess Medical Center), Guido Beldi(University of Bern), Ben Atkinson(Beth Israel Deaconess Medical Center), Yan Wu(Beth Israel Deaconess Medical Center)
British Journal of Haematology
June 5, 2008
Cited by 65


Related Papers